466 related articles for article (PubMed ID: 22590765)
21. [The effect of one year therapy with recombinant human growth hormone (rhGH) on growth velocity, calcium-phosphorus metabolism, bone mineral density and changes in body composition in children with growth hormone deficiency (GHD)].
Zak T; Basiak A; Zubkiewicz-Kucharska A; Noczyńska A
Pediatr Endocrinol Diabetes Metab; 2010; 16(1):39-43. PubMed ID: 20529605
[TBL] [Abstract][Full Text] [Related]
22. The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency.
Deepak D; Daousi C; Javadpour M; Clark D; Perry Y; Pinkney J; Macfarlane IA
Growth Horm IGF Res; 2010 Jun; 20(3):220-5. PubMed ID: 20185347
[TBL] [Abstract][Full Text] [Related]
23. Safety of growth hormone treatment in pediatric patients with idiopathic short stature.
Quigley CA; Gill AM; Crowe BJ; Robling K; Chipman JJ; Rose SR; Ross JL; Cassorla FG; Wolka AM; Wit JM; Rekers-Mombarg LT; Cutler GB
J Clin Endocrinol Metab; 2005 Sep; 90(9):5188-96. PubMed ID: 15899952
[TBL] [Abstract][Full Text] [Related]
24. Effects of growth hormone on cognitive function.
Ross JL
Horm Res; 2005; 64 Suppl 3():89-94. PubMed ID: 16439850
[TBL] [Abstract][Full Text] [Related]
25. Height velocity targets from the national cooperative growth study for first-year growth hormone responses in short children.
Bakker B; Frane J; Anhalt H; Lippe B; Rosenfeld RG
J Clin Endocrinol Metab; 2008 Feb; 93(2):352-7. PubMed ID: 18000092
[TBL] [Abstract][Full Text] [Related]
26. Growth hormone treatment for short stature in children born small for gestational age.
Jung H; Rosilio M; Blum WF; Drop SL
Adv Ther; 2008 Oct; 25(10):951-78. PubMed ID: 18836868
[TBL] [Abstract][Full Text] [Related]
27. Growth hormone treatment completely normalizes adult height and improves body composition in Prader-Willi syndrome: experience from KIGS (Pfizer International Growth Database).
Lindgren AC; Lindberg A
Horm Res; 2008; 70(3):182-7. PubMed ID: 18663319
[TBL] [Abstract][Full Text] [Related]
28. Growth hormone therapy in short stature.
Knudtzon J; Aarskog D
Pediatrician; 1987; 14(3):172-7. PubMed ID: 3331011
[TBL] [Abstract][Full Text] [Related]
29. Genetic predictors of long-term response to growth hormone (GH) therapy in children with GH deficiency and Turner syndrome: the influence of a SOCS2 polymorphism.
Braz AF; Costalonga EF; Trarbach EB; Scalco RC; Malaquias AC; Guerra-Junior G; Antonini SR; Mendonca BB; Arnhold IJ; Jorge AA
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1808-13. PubMed ID: 24905066
[TBL] [Abstract][Full Text] [Related]
30. Growth hormone therapy and children with idiopathic short stature: a viable option?
Willhaus J
Pediatr Nurs; 1999; 25(6):662-5. PubMed ID: 12024388
[TBL] [Abstract][Full Text] [Related]
31. Growth hormone responsiveness: peak stimulated growth hormone levels and other variables in idiopathic short stature (ISS): data from the National Cooperative Growth Study.
Moore WV; Dana K; Frane J; Lippe B
Pediatr Endocrinol Rev; 2008 Sep; 6(1):5-8. PubMed ID: 18806719
[TBL] [Abstract][Full Text] [Related]
32. Growth hormone-induced increases in skeletal muscle mass alleviates the associated insulin resistance in short children born small for gestational age, but not with growth hormone deficiency.
Martin DD; Schweizer R; Schönau E; Binder G; Ranke MB
Horm Res; 2009; 72(1):38-45. PubMed ID: 19571558
[TBL] [Abstract][Full Text] [Related]
33. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome.
Blum WF; Cao D; Hesse V; Fricke-Otto S; Ross JL; Jones C; Quigley CA; Binder G
Horm Res; 2009; 71(3):167-72. PubMed ID: 19188742
[TBL] [Abstract][Full Text] [Related]
34. Growth hormone prescribing patterns in the UK, 2013-2016.
Shepherd S; Saraff V; Shaw N; Banerjee I; Patel L
Arch Dis Child; 2019 Jun; 104(6):583-587. PubMed ID: 30567827
[TBL] [Abstract][Full Text] [Related]
35. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).
Craig ME; Cowell CT; Larsson P; Zipf WB; Reiter EO; Albertsson Wikland K; Ranke MB; Price DA;
Clin Endocrinol (Oxf); 2006 Aug; 65(2):178-85. PubMed ID: 16886957
[TBL] [Abstract][Full Text] [Related]
36. Hormone replacement therapy in children: The use of growth hormone and IGF-I.
Pfäffle R
Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):339-52. PubMed ID: 26051295
[TBL] [Abstract][Full Text] [Related]
37. Final height in children with idiopathic growth hormone deficiency treated with a fixed dose of recombinant growth hormone.
Rachmiel M; Rota V; Atenafu E; Daneman D; Hamilton J
Horm Res; 2007; 68(5):236-43. PubMed ID: 17396034
[TBL] [Abstract][Full Text] [Related]
38. Growth hormone treatment for short stature: a review of psychosocial assumptions and empirical evidence.
Gardner M; Sandberg DE
Pediatr Endocrinol Rev; 2011 Dec; 9(2):579-88; quiz 589. PubMed ID: 22397142
[TBL] [Abstract][Full Text] [Related]
39. Long-term effects of growth hormone therapy on patients with Prader-Willi syndrome.
Sipilä I; Sintonen H; Hietanen H; Apajasalo M; Alanne S; Viita AM; Leinonen E
Acta Paediatr; 2010 Nov; 99(11):1712-8. PubMed ID: 20545932
[TBL] [Abstract][Full Text] [Related]
40. Growth hormone treatment in Japan: past, present, and future.
Tanaka T
Pediatr Endocrinol Rev; 2012 Oct; 10 Suppl 1():89-97. PubMed ID: 23330250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
